Emtricitabine, Tenofovir alafenamide, Elvitegravir, Cobicistat

GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA

200 mg + 10 mg + 150 mg + 150 mg comprimido recubierto con películaSpainMarketedAuthorised 26 Nov 2015

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

GenvoyaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Emtricitabine, Tenofovir alafenamide, Elvitegravir, Cobicistat

GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA

200 mg + 10 mg + 150 mg + 150 mg comprimido recubierto con películaSpainMarketedAuthorised 26 Nov 2015

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

GenvoyaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Genvoya 90 mg/90 mg/120 mg/6 mg, filmomhulde tabletten

Netherlands · Filmomhulde tablet · Gilead Sciences Ireland UC

GENVOYA Film-coated TabletSaudi Arabia · Patheon INC

GenvoyaUnited States · 150MG; 150MG; 200MG; 10MG BASE · tablet · Gilead Sciences INC

Elvitegravir, Cobicistat, Emtricitabine and Tenofovir AlafenamideUnited States · 120MG, 150MG, 200MG … · tablet · Apotex INC

Packs

Pack	Code	Status
GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos	708963

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Emtricitabine, Tenofovir alafenamide, Elvitegravir, Cobicistat
Strength: 200 mg + 10 mg + 150 mg + 150 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 26 Nov 2015
Registration: 1151061001
Marketing authorisation holder: Gilead Sciences Ireland Unlimited Company
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/15/1061

Emtricitabine + Tenofovir alafenamide + Elvitegravir + Cobicistat · 200 mg + 10 mg + 150 mg + 150 mg · comprimido recubierto con película

Spain